CB1 Cannabinoid Receptor Ligands

Author(s): Ganesh A. Thakur, Spyros P. Nikas, Alexandros Makriyannis.

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 5 , Issue 7 , 2005

Become EABM
Become Reviewer


The CB1 receptor is expressed in the central nervous system and numerous other tissues including heart, lung and uterus and has been recognized as an important therapeutic target for pain, appetite modulation, glaucoma, multiple sclerosis and other indications. An interesting feature of this GPCR is its ability to be activated by a number of structurally different classes of compounds, thus, raising the possibility of multiple activated forms of the receptor. Understanding of the structure-activity relationships of cannabinergic ligands has paved the road for the development of novel ligands exhibiting receptor subtype selectivity and efficacy. This review highlights the important CB1 cannabinergic ligands developed to date.

Keywords: cannabinoid receptors, cb agonists, cb antagonists, cb selectivity

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2005
Page: [631 - 640]
Pages: 10
DOI: 10.2174/1389557054368772
Price: $58

Article Metrics

PDF: 13